Gout
Conference Coverage
Large population-based study underscores link between gout, CVD event risk
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New...
Conference Coverage
Serum urate level governs management of difficult-to-treat gout
LAS VEGAS – Insufficient dosing of urate lowering therapy may be a reason for perceived treatment resistance.
From the Journals
Heart disease raises risk of severe cutaneous adverse reactions to allopurinol
The study looked at allopurinol users over an 18-year period in British Columbia.
From the Journals
Modifiable risk factors account for many gout cases
A substantial proportion of gout cases are attributable to four modifiable lifestyle risk factors, including BMI and alcohol intake.
From the Journals
Almost one-third of ED patients with gout are prescribed opioids
A diagnosis of diabetes or polyarticular gout attack, and prior opioid use were all associated with a more than 100% higher odds of opioid...
Video
Lowering hyperuricemia improved endothelial function but failed as an antihypertensive
MADRID –
News from the FDA/CDC
Arthritis joint pain, inactivity vary greatly across U.S.
The Southeast has the highest rates of adults with severe joint pain and physical inactivity, the CDC reports.
From the Journals
Colchicine reduces inflammatory markers associated with metabolic syndrome
Colchicine was linked to lower levels of inflammatory markers and improved fasting insulin levels and glucose effectiveness.
Conference Coverage
Industry-funded rheumatology RCTs are higher quality
MAUI, HAWAII – An analysis of 20 years of rheumatology clinical trials.
Conference Coverage
Concomitant methotrexate boosts pegloticase efficacy in gout patients
MAUI, HAWAII – “This really did change my practice,” said Alvin F. Wells, MD.
News from the FDA/CDC
FDA approves liquid colchicine for gout
Physicians can easily make dose adjustments with new form of colchicine, says Romeg Therapeutics.